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Abstract
Cerebral autoregulation (CA) refers to the properties of the brain vascular bed to 
maintain cerebral perfusion despite changes in blood pressure (BP). Whereas 
classic studies have assessed CA during changes in BP that have a gradual 
onset, dynamic studies quantify the fast modifications in cerebral blood flow (CBF) 
in relation to rapid alterations in BP. There is a lack of standardization in the 
assessment of dynamic CA. This review provides an overview of the methods that 
have been applied, with special focus on the elderly. We will discuss the relative 
merits and shortcomings of these methods with regard to the aged population. 
Furthermore, we summarize the effects of variability in BP on CBF in older people. 
Of the various dynamic assessments of CA, a single sit-tostand procedure is a 
feasible and physiologic method in the elderly. The collection of spontaneous beat- 
to-beat changes in BP and CBF allows estimation of CA using the technique of 
transfer function analysis. A thorough search of the literature yielded eight studies 
that have measured dynamic CA in the elderly aged < 75 years. Regardless of the 
methods used, it was concluded from these studies that CA was preserved in this 
population.
Introduction
The brain has a high metabolic demand and therefore requires adequate 
nutritional flow. To maintain stable cerebral blood flow (CBF), the brain’s 
vasculature must respond to changes in arterial blood pressure (BP) or intracranial 
pressure. Thus, cerebral blood vessels have an inherent ability to keep CBF 
constant over a wide range of systemic BP levels, by means of myogenic, 
neurogenic, or metabolic mechanisms.1,2 In response to a variation in perfusion 
pressure (mean arterial pressure-intracranial pressure), an adaptation in 
cerebrovascular resistance (CVR) will cause CBF to return to its baseline. This 
hemodynamic process is known as cerebral autoregulation (CA).1,3
The term ‘autoregulation’ within the cerebral circulation was introduced by 
Lassen4. His review covered more than 200 clinical studies assessing CBF using 
the inert gas method (which measures arterial-venous gas difference), developed 
by Kety and Schmidt, and the indicator dilution method (which measures the 
venous dilution of an intraarterially injected indicator), developed by Gibbs, 
Maxwell, and Gibbs.4 Notably, the more recently developed positron emission 
tomography scanning technique enabling, for example, measurement of cerebral 
oxygen metabolism, is founded on these principles.
Lassen’s review included the now classic studies regarding static CA (sCA), 
which describes the response of CBF, averaged over a longer period of time, to 
long-term changes in BP with gradual onset. By plotting these changes in CBF 
and BP, it was found that CBF remains constant over a wide range of BP 
changes—the ‘plateau phase,’ with the upper and lower limits forming the 
boundaries of CA. It should be noted, however, that this classic single curve was a 
composite of many studies, and critical analysis of this work brings into question its 
validity.1 Frequently, a slight slope exists over the pressure range where the 
supposed plateau had been plotted.5 Predictions from a physiologic computer 
model are that in between the lower and upper boundaries of this plateau phase, 
CBF actually changes from 80% to 120% of baseline.6 Nonetheless, between 
these upper and lower limits, autoregulation of CBF is effective. It is important to 
realize that these boundaries are not fixed.1 Chronic hypertension, for example, 
shifts these limits of autoregulation toward higher BP levels. This adaptation 
protects the brain against hypertension, but may also render it more vulnerable to 
hypoperfusion during episodes of hypotension.1
The classic studies of CA are performed in the semi-steady state. The changes 
in BP occur gradually and the measured CBF values reflect the results of 
adaptation of CVR to the new, stable BP value. In other words, these studies 
assess the outcome of CA rather than the process of CA itself. In terms of
maintaining sufficient nutritional blood flow, these semi-steady state studies 
provide no information as to whether a period of hypoperfusion precedes the 
eventual return to stable perfusion. Furthermore, the clinical applicability of sCA 
estimation is limited, because it requires pharmacological interventions to establish 
a sustained period of hypertension and hypotension.
More recent technological developments, such as transcranial Doppler 
ultrasonography (TCD) and servo-controlled finger photoplethysmography 
(Finapres), have offered possibilities to investigate the dynamics of the pressure- 
flow relationship of the cerebral circulation. In contrast to the classic studies, 
dynamic studies of CA quantify the fast modifications in CBF velocity (CBFV) in a 
major cerebral artery in relation to rapid alterations in BP within the upper and 
lower limits (plateau phase) of sCA. This approach allows differentiation of the CA 
response to fluctuations in beat-to-beat BP of different magnitudes and durations. 
Also in contrast to the classic studies, dynamic studies can identify episodes of 
reduced flow in this major perfusing artery in the period needed for CBF to return 
to baseline after hypotension. However, these dynamic studies are not able, at 
present, to measure flow at the brain tissue level. For studies of dynamic CA 
(dCA), a pharmacological intervention is not required, and the method is entirely 
noninvasive, which makes it clinically suitable. Recently, dCA has been shown to 
be impaired in several conditions that are highly prevalent in the elderly, such as 
ischemic stroke7 and carotid stenosis8. Therefore, the vulnerable brain in these 
patients is insufficiently protected against the effects of rapid BP changes. 
Furthermore, postprandial hypotension or orthostatic hypotension, both common 
hypotensive syndromes in elderly patients9, may lead to cerebral symptoms like 
syncope, falls, and dizziness.10,11 Whether these hypotensive syndromes result in 
symptoms and clinical signs and thus have clinical consequences is largely 
determined by the process of CA.12,13
In hypertension, dCA has been addressed only in those who were < 75 years 
old. In mild-to-moderate hypertension, dCA is unimpaired14, and reduction of BP to 
achieve normotension is not associated with cerebral hypoperfusion in middle- 
aged subjects15 and elderly subjects < 75 years.16 Although the beneficial effects 
of antihypertensive treatment in preventing cardiac disease and stroke are well 
known17, whether it is similarly safe to treat hypertension in the elderly cannot be 
answered at present.18
In contrast with studies of sCA, no uniform method exists to measure, analyze, 
and report dCA. In fact, the various methods applied differ in the type of BP stimuli 
(spontaneous or induced BP fluctuations) and in the model for analysis and 
interpretation.
Studies describing dCA in the elderly and in diseases affecting older people 
have used different methods to evaluate the dynamic autoregulatory capacity of 
the brain. The important clinical question whether aging affects CA can therefore 
only be attempted to be answered after careful interpretation of these different 
methodologies.
In this review, we will first provide an overview of measurements of the various 
parameters that have been applied to assess dCA. Also, we will discuss the 
different methods to provoke cerebral hemodynamics and allow dynamic 
assessments of CA. Later, we present an overview of dynamic studies of CA in the 
elderly and will discuss the interaction between CA and disease.
Review of Methods 
Measurements
To evaluate the dynamic process of the autoregulatory capacity of the human 
brain, assessment of BP and CBF with high temporal resolution is essential, and 
photoplethysmography (Finapres) and TCD enable these measurements, 
respectively.19-21 During all measurements of cerebral hemodynamics, changes in 
end-tidal CO2 should be closely monitored. We will address the measurements of 
these parameters in more detail below.
Cerebral blood flow: The inert gas method and the indicator dilution methods 
measure global CBF as blood flow in volume per unit weight per unit time (for 
example, mL per 1 00 g per min). These methods are rather invasive and time­
consuming, and the indicator dilution methods have a low temporal resolution.
In contrast, TCD is noninvasive, easy to use, and offers a very high temporal 
resolution (< 0.1 secs) to monitor changes in CBF.19 Transcranial Doppler 
ultrasonography measures flow-velocity, in centimeter per second, in one of the 
supplying arteries of the brain, usually the middle cerebral artery (MCA). The flow- 
velocity in the MCA measured by TCD is determined by both the flow in the MCA 
and by its diameter, or rather its cross-sectional area. Therefore, changes in 
flowvelocity recorded with TCD represent changes in flow, provided that the 
diameter of the insonated vessel remains constant. It has been shown in 
(neuro)surgical patients that the diameter of the MCA does not significantly 
increase or decrease during, respectively, a mean decrease or increase in BP of 
30 (s.d. 16)mm Hg.22,23 Furthermore, in healthy subjects, lower body negative 
pressure at 20 or 40mm Hg induced decreases in flow-velocity in the MCA, 
whereas diameter changes did not occur during these tests.24 These 
hemodynamic changes are similar to those encountered in dynamic tests of
autoregulation, as will be illustrated later. In this review, consistent with the 
literature on this subject, flow-velocity in the MCA as recorded with TCD is denoted 
as CBFV, and it is assumed that the changes in CBFV reflect changes in CBF. 
However, in contrast with other methods (see above), this representation of CBF 
does not include brain tissue weight. As a further caveat, these measurements 
only reflect changes in flow for the perfused territory. It is conceivable that the 
perfused territory of the insonated vessel (mostly the MCA) might change under 
pathologic conditions, such as focal cerebral ischemia or vasogenic edema, and 
under nonpathologic conditions, such as hyper- or hypocapnia and extreme 
hypoxia.
Some TCD devices include a provision to determine an index of the cross­
sectional area of the vessel being insonated, according to the backscattered 
power. In surgical patients, the vessel area increased after inhalation of isoflurane, 
whereas CBFV remained unchanged.25 A similar observation was made during 
combined hypoxia and hypercapnia, whereas during either hypoxia or hypercapnia 
alone, no change in vessel diameter was noted.26 These data suggest that stability 
of vessel diameter cannot be assumed under all conditions.
Arterial blood pressure: Blood pressure can be measured noninvasively and beat 
to beat with a servo-controlled finger photoplethysmography as in the Finapres 
device.21 The obtained BP recordings using this device correspond well to invasive 
BP recordings in the brachial artery under various conditions, including during 
assessment of Dca.20
The combination of Finapres and TCD has made it possible to study the 
dynamic process of CA.
During BP recordings with Finapres, the finger is held at heart level. In 
autoregulation research using Finapres, changes in mean BP measured at heart 
level are used to estimate changes in cerebral perfusion pressure both in the 
supine position and during standing or head-up tilt. However, it has been argued 
that finger BP does not represent cerebral perfusion pressure because of the 
hydrostatic gradient between finger and brain when the subject is sitting or 
standing. Conversely, if the heart-brain circulation is considered to represent a 
closed-loop system, the subject’s body position should not matter. This is based 
on the assumption that the intracranial and cerebral venous pressures are 
relatively low and constant and that, during standing or sitting, hydrostatic 
components of intracranial and cerebral venous pressure at head level are 
reduced commensurate with arterial pressure as for a closed circulatory system.27 
However, controversies regarding these assumptions must be recognized.28
Currently, there are no experimental data that either unequivocally support or 
disprove this theory.29
Carbon dioxide: Monitoring of CO2 , mostly as endtidal CO2 , is essential in studies 
on cerebral perfusion and autoregulation. CO2  is a very potent cerebral 
vasodilator, and hypercapnia may cause a 3% to 5% increase in CBF per mm Hg 
rise in endtidal CO2.30,31 Hypocapnia induces vasoconstriction and can reduce 
CBF by 2% to 3% per mm Hg reduction in end-tidal CO2 . Thus, changes in 
respiratory pattern during tests of autoregulation may greatly confound the 
measurements of CBF. Moreover, CO2  causes sympathetic activation and may 
cause a substantial increase in BP.31
Methods to Induce Hemodynamic Changes
Essential for the evaluation of CA dynamics is to observe the response of cerebral 
perfusion to an alteration in BP. There are several potential methods to induce 
oscillations or rapid changes in BP, of which the thigh cuff method was the first to 
be introduced.
Step decreases in blood pressure: Aaslid et al.32 introduced the thigh cuff method, 
which induces step decreases in BP by rapid deflation of cuffs around both thighs 
after an inflation lasting at least 2 mins. A different approach to reduce BP is lower 
body negative pressure. If the atmospheric pressure surrounding the lower body 
(which is enclosed in a sealed box) is reduced, this reduces the extravascular 
pressure, which causes dilatation of veins and a lowered vascular resistance, 
increasing the flow to the lower limbs.33
Of interest, even without a change in mean BP, CBFV decreases during lower 
body negative pressure.15,34 The exact mechanism that is responsible for this 
reduction in CBFV during lower body negative pressure remains uncertain; 
recently it was shown that it is not likely due to cerebral vasoconstriction caused by 
sympathetic activation.15
Both the thigh cuff and the lower body negative pressure techniques have been 
developed to allow assessment of dCA in the supine position. This is of relevance 
in patients who are confined to bed, for example, in head trauma patients in an 
intensive care unit. The thigh cuff method can be painful35 and is not a method of 
choice in aged subjects, although pain can be reduced if large-sized cuffs are 
used (R Aaslid, personal communication). Lower body negative pressure is also 
an uncomfortable procedure that is not well tolerated and cannot be applied in 
obese subjects. Therefore, both techniques are not ideally suited for the
assessment of dCA in elderly patients. As the majority of these patients can be 
tested in an upright position, alternative methods to induce oscillations in BP can 
be used more efficiently.
A simple and feasible method used to assess dCA is the Valsalva maneuver, 
which causes characteristic changes in BP and CBFV.36 In this procedure, the 
decrease in BP is due to elevation of intrathoracic and intraabdominal pressure 
induced by straining. With the increase in intrathoracic pressure, the venous return 
decreases, causing a reduction in cardiac output and hence a decrease in BP, 
which in turn leads to baroreflexmediated vasoconstriction.37 The increase in 
intrathoracic pressure also causes an increase in intracranial pressure38, leading 
to a considerably stronger reduction in the cerebral perfusion pressure than 
indicated by the BP decrease. In addition, an increase in end-tidal CO2 pressure 
during the Valsalva maneuver has been observed39 and the effect on cerebral 
vessels of a change in arterial CO2  pressure has to be taken into account. These 
observations suggest that the Valsalva maneuver is too complex a method to 
quantify the effects of changes in BP on CBFV.
Placing a hand in ice water (cold pressor test), as well as isometric exercise 
such as sustained handgrip, result in increased BP by stimulating sympathetic 
efferent pathways. Both methods have been used for the assessment of dCA.40-42 
However, the CBFV response to these tests is very heterogeneous.
A different stimulator of the sympathetic nervous system is passive head-up 
tilt.43 Cerebral blood flow velocity decreases during head-up tilt, and this test has 
been used to assess dCA in patients with syncope.44 However, during head- 
upright tilt in healthy subjects, a slight but significant decrease in both end-tidal 
CO2 pressure and CBFV has been observed, without a change in the rate of 
breathing.45 The change in end-tidal CO2 is thought to be due to the changes in 
the ventilation-perfusion relationship during tilting.
The role of the sympathetic nerve system in the regulation of CBF remains 
controversial. The cerebrovascular bed is well innervated by both sympathetic and 
parasympathetic nerve fibers46, but most studies in animals have found that 
baseline CBF does not change after autonomic denervation.47 On the contrary, 
Zhang et al.48 found that dCA was altered markedly after ganglion blockade, 
suggesting that autonomic neural control of the cerebral circulation is involved in 
beat-to-beat regulation of CBFV. Therefore, possible direct effects on cerebral 
vessels of sympathetic activation have to be taken into account when using these 
tests to induce an increase in BP and assess dCA.
A more straightforward technique used to assess dCA is the sit-to-stand 
procedure, which induces a depressor change in BP and CBFV. The reduction in
BP (of approximately 25%), resulting from an immediate and marked decrease in 
total peripheral resistance upon standing, is presumably caused by 
cardiopulmonary baroreflex mechanisms.49 This characteristic decrease in BP, 
named initial orthostatic hypotension, is absent in passive tilt testing.50 After this 
initial decrease in total peripheral resistance, the arterial baroreceptors respond to 
the hypotension and the cardiopulmonary receptors react to the decline in preload, 
leading to an increase in total peripheral resistance. In Figure 1, we present a 
typical BP and CBFV response in a healthy elderly subject during a sit-to-stand 
maneuver. Standing up causes a small decrease in end-tidal CO2, which cannot, 
however, explain the immediate decrease in CBFV upon standing.51
Figure 1. Blood pressure (BP) and cerebral blood flow velocity (CBFV) response during a sit to 
stand maneuver
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Continuous beat-to-beat blood pressure (BP) and cerebral blood flow-velocity (CBFV) measurements 
during a sit to stand maneuver in a healthy elderly subject. Beat-to-beat data were resampled at 2 Hz to 
create an equal time base. The subject starts standing after 30 s.
When changing position from sitting to standing, the Doppler probe remains in the 
same spatial in relation to the heart and Finapres finger cuff throughout the 
procedure in contrast to passive head-up tilt, and thus avoiding the issue of a 
possible hydrostatic effect on cerebral perfusion pressure. The sit-to-stand 
procedure is a useful and feasible method to test dCA in elderly subjects. An 
additional benefit of this method is that it represents a physiologic challenge that 
occurs in daily life.
Oscillations in blood pressure: The techniques described above provide a single­
step challenge to cerebral hemodynamics. In contrast, periodic squatting52, 
oscillatory lower body negative pressure53,54, oscillatory thigh cuff inflation and 
deflation55, and periodic breathing56 give rise to almost sinusoidal oscillations in
BP. When BP is forced to oscillate at a determined frequency, CBFV follows these 
induced oscillations. These induced periodic variations in BP and CBFV can be 
used for the assessment of dCA.
A disadvantage of the periodic breathing approach is that it may lead to a larger 
tidal volume and induce hypocapnia. Instructing patients to breathe slowly and 
with small tidal volumes can prevent hypocapnia. However, older subjects and 
subjects with cognitive impairment may not be able to adequately perform this 
technique. The same holds true for the technique of periodic squatting. The 
disadvantages of lower body negative pressure and thigh cuffs have been 
described above. A single sit-to-stand maneuver is well tolerated in elderly 
subjects. Therefore, repeated sit-stand maneuvers may be easier to perform and 
better tolerated in the elderly population. However, this procedure has never been 
tested to produce sinusoidal oscillations in BP. It could be useful to test a well- 
developed, repeated, sit-to-stand protocol in experiments in the elderly population.
Fortunately, it is also possible to estimate dCA without inducing changes in BP. 
Blood pressure oscillations ranging from 0.02 to 0.4 Hz occur in humans during 
daytime and nighttime without an externally triggered BP manipulation, 
independent of stimuli of daily life.57 If spectral analysis is applied to this BP 
variability, three frequency ranges are noticeable: one around the respiratory 
frequency showing peaks at 12 cycles per minute (the high-frequency region, 
respiratory waves, around 0.2 to 0.4 Hz); one around 6 cycles per minute related 
to variations in vasomotor tone (mid-frequency region, Mayer waves at 0.1 Hz); 
and the lowest frequency region, of which the cause is speculative, around 1 cycle 
per minute (low-frequency region, 0.02 to 0.07 Hz; alternatively named the very 
low frequency).58 Similarly, CBFV measured by TCD is not constant over time. 
Lindegaard et al.59 found individual ranges of spontaneous fluctuations between 
±15% and ±35% of the mean flow in patients after carotid endarterectomy. Diehl et 
al (1991) found oscillations up to 30% of the mean CBFV with low-frequency 
oscillations between 0.4 and 9 cycles per min. In conclusion, spontaneous 
fluctuations of BP and CBFV may be useful for the assessment of dCA.60 This 
mechanism limits the need for the above-mentioned methods to induce alterations 
in BP and seems to be the simplest method for the assessment of dCA in a clinical 
setting.
Baseline (resting) measurements of BP are the most physiologic situation to 
assess dCA. However, they depend on the magnitude of the spontaneous 
oscillations. This magnitude, in turn, depends on the variability of BP, which is not 
always high enough to allow estimations of dCA. Furthermore, spontaneous 
oscillations in the low-frequency range appear inconsistently. These reasons may
explain the lack of coherence between BP and CBFV (we will further explain and 
discuss the coherence below) in approximately 10% of all spontaneous oscillation 
recordings.61 In this situation, augmented oscillations are expected to increase 
coherence between BP and CBFV, and it will be necessary to induce these 
oscillations using repeated maneuvers as described above.
Quantifications of Dynamic Cerebral Autoregulation
After a change in BP, the relationship between CBF and BP has to be quantified. 
Here, we will discuss the methods that are most commonly used in clinical 
situations. These methods approach the relationship between BP and CBF as if it 
is linear. It should be noted that more complex mathematical models have been 
developed that allow for nonlinear dynamics.62
In Table 1, we provide an overview of the different quantifications discussed 
below.
Cerebrovascular resistance: Linear system analysis facilitates the examination of 
the transfer of BP oscillations to CBF as a measure of autoregulation. It quantifies 
the extent to which the BP input signal is reflected in the CBFV output signal. The 
regulator between the input and output is the resistance of the small cerebral 
vessels distal to the site of insonation. According to Ohm’s law, this resistance is 
defined as mean BP/CBF. Thus, CVR is defined by mean BP divided by mean 
CBF:
CVR = BPmean
CBFmean
The use of CBF to calculate CVR takes into account the brain weight, whereas 
studies that use TCD and measure flow-velocity lack this tissue weight. These 
studies calculate the CVR index (CVRi), which is defined by the mean BP divided 
by mean CBFV:
BPmean CVRi = ---------------
CBFVmean
Studies that use CBFV ideally would have to take into account the cross-sectional 
area factor between CBF and CBFV in addition to brain tissue weight in their 
estimates of CVR. Furthermore, it should be emphasized that the use of the ratio 
between BP and CBF (velocity) to represent CVR (index) corresponds to a model
where the cerebrovascular circulation is characterized by a single parameter. This 
calculation infers from Ohm’s law and is based on a number of hypotheses, and 
resistance is not measured directly.
Gosling’s pulsatility index (PI) is sometimes used to reflect CVR.63 This index is 
defined as the difference between systolic and diastolic extremes of CBFV divided 
by the mean CBFV:
pi = CBFVsys -  CBFVdias 
CBFVmean
The PI changes with alterations in CVRi in the following manner. CVRi and the PI 
are both inversely correlated to CBFV in steady state (e.g., reduction in CVRi 
causes an increase in CBFV and a reduction in PI). Under these stable conditions, 
a quantitative relationship indeed exists between CVR and PI. However, during 
neurally mediated syncope, CVRi decreases, whereas the PI increases.44 
Therefore, the PI cannot serve as an adequate parameter to assess dCA.
Another estimate for vasomotor resistance is the critical closing pressure, 
determined from the systolic-diastolic pressure-flow relationship within each 
heartbeat. The critical closing pressure of the cerebral circulation indicates the 
value of BP at which CBF is projected to approach zero.64 This value is obtained 
by linear extrapolation of the BP and CBFV values in the systolic to diastolic range 
that were obtained within each cardiac cycle. The slope of this ‘intrabeat’ BP- 
CBFV curve is nonlinear, however, and therefore it remains uncertain if the true 
critical closing pressure can be accurately predicted by linear extrapolation. The 
critical closing pressure has not been validated in disease states or in elderly 
subjects, and further research will be necessary to determine if it could be a useful 
tool (for a review, we refer to Panerai64).
Table 1: Overview of the various dynamic quantifications of cerebral autoregulation in the time 
domain
CA measurement Abbreviation Unit / Value Definition
CerebroVascular
Resistance
CVR mmHg per mL per min BPmean
CBFmean
CerebroVascular 
Resistance Index
CVRi mmHg per cm per sec BPmean
CBFVmean
Pulsatility Index PI CBFVsys -  CBFVdias 
CBFVmean
Critical Closing Pressure CrCP mmHg The extrapolated value of BP at 
which CBF approaches zero.
Rate of Recovery RoR CBFV per sec ACVR / AT
ABP
Autoregulatory Index ARI 0 -  9 9 models for CA:
0 indicates no autoregualion 
9 indicates very fast regulation 
Pearson’s correlation coefficient 
between BP and CBFV
Correlation Coefficient Mx 0 -  1
BP, blood pressure; CBFV, cerebralblood flow velocity
Time Domain versus Frequency Domain
A linear system can be described in the time domain or in the frequency domain. 
We will first describe the techniques used in the time domain.
The time domain is used to describe the analysis of physical signals with 
respect to time. The signal’s value is known at various discrete time points and a 
time domain graph shows how a signal changes over time.
Rate of recovery: The time of CBFV recovery after a single pressor or depressor 
stimulus is taken as a measure for the efficiency of dCA. One of the quantifications 
used in this approach is the rate of recovery. The rate of recovery is defined as the
32normalized changes in CVRi per second during a BP decrease
This rate uses CVRi in the calculation, but, as mentioned above, this does not take 
into account the cross-sectional area factor between CBF and CBFV and lacks 
brain weight.
Furthermore, this method has not been tested specifically in an elderly 
population.
Autoregulatory index: Using the alterations in CVRi in relation to the change in BP 
during thigh cuff maneuvers, Tiecks et al.65 introduced the autoregulatory index. 
For an observed decrease in BP, a hypothetical CBFV curve without 
autoregulation is calculated. Eight other different computer models of possible 
flow-velocity curves are calculated as well, each assuming a higher degree of 
dCA. An autoregulatory index of 0 indicates that CBFV passively follows BP (in 
other words, the percentage change in CBFV is equal to that of BP); a value of 9 
indicates that CBFV recovers much faster than BP.
Panerai et al.66 showed that this model can also be used to grade autoregulation 
using baseline recordings of BP and CBFV, estimating the impulse response
Rate o f Recovery
ACVR / AT 
ABP
function. This function expresses the relationship between BP and CBFV after a 
very short, impulse-like disturbance in BP.
The autoregulation index has been applied in elderly subjects with hypertension, 
stroke, and carotid sinus syndrome (see section on CA in aging and comorbidity).
Correlation index: In patients with head injury, Czosnyka et al.67 calculated 
Pearson’s correlation coefficients between consecutive samples of averaged 
cerebral perfusion pressure and flow velocity for every 3-min period determining a 
correlation index known as ‘Mx.’ Lang et al.68 showed that this index is valid if BP 
is used instead of cerebral perfusion pressure in these patients. This obviates the 
need for the invasive measurement techniques to determine intracranial pressure. 
Presently, however, the Mx has not been validated in nonbrain trauma patients, 
and the proposed cutoff values were not valid in healthy subjects.69
The Frequency Domain
In the frequency domain, physical signals are described with respect to frequency.
In Figure 2 we illustrate two signals that show clear repetitive patterns over time. 
In fact, they can be described as two sinusoidal waveforms (oscillations) with a 
given period, T, and amplitudes A and B. The frequency in hertz (Hz) is calculated 
from the period:
T
Giller was the first to use frequency domain analysis to describe the relation 
between oscillatory patterns of BP and CBFV.70
Figure 2 Transfer function analysis
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Graphical explanation of the concept of transfer function analysis. Two sinusoidal waveforms with the same 
period (T) are presented. Waveform frequency (F) is defined as 1/T.(A) The solid line represents waveform
1 (W1), with amplitude.(B) The dashed line represents waveform 2 (W2), with amplitude. The gain is the 
damping effect between W1 and W2, and the phase shift represents the time delay between W1 and W2. 
Provided that W1 is the input and W2 is the output of the transfer function, the regulator in this system 
attenuates the amplitude of the input leading to a lower amplitude (gain) of W2. The phase shift of W2 
characterizes the displacement in time of this waveform relative to W1.
In Figure 3A, we present an example of the spontaneous oscillations in BP and 
CBFV recorded in a healthy old subject over a period of 5 mins of rest in sitting 
position. The signals are composed of several different oscillations with different 
periods (and thus frequencies) and amplitudes. Spectral analysis makes
it possible to create the frequency domain graph that shows the frequency 
spectrum of these different oscillations that are hidden in the signal. In Figure 3B,
we illustrate the power spectra of the two signals presented in Figure 3A. A power 
spectrum is a frequency graph that describes how much of the signal lies within a
given frequency.
Figure 3A/B
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Figure 3 (A) Spontaneous oscillations of blood pressure (BP) and cerebral blood flow velocity (CBFV). Five 
minutes of continuous BP and CBFV measurements in a healthy elderly subject in sitting position, showing 
spontaneous oscillations in both signals. (B) Power spectra of BP and CBFV. The power spectra of BP and 
CBFV data presented in panel (A), obtained after spectral analysis. The power spectra describe how much 
of the BP and CBFV oscillations lie within a given frequency. Note the different scales on the y axis 
illustrating the difference of the magnitude of the oscillations in BP and CBFV.
In the frequency domain analysis, the regulation of CBF in response to changes in 
BP can be described using transfer function analysis. Transfer function analysis 
makes it possible to examine the transfer of the BP oscillations to CBF as a 
measure of autoregulation. It quantifies the extent to which the input signal, BP, is 
reflected in the output signal, CBF, with CA as the regulator between the input 
(BP) and output (CBF).
The regulation of CBFV is effective in the low-frequency range of BP 
fluctuations, but not in the high-frequency range because of the time delay 
required to initiate cerebrovascular adaptations to the changes in perfusion 
pressure. Therefore, CA functions like a high-pass filter, allowing rapid BP
0
changes to be transmitted to CBFV, whereas slow BP changes are filtered. 
Cerebral blood flow velocity in relation to BP can therefore be expressed by 
transfer function analysis using a high-pass filter model in the frequency range of 
0.07 to 0.30 Hz.71,72
Gain, phase, and coherence: The transfer function between the oscillations in BP 
and CBFV in this autoregulatory system is characterized by three parameters: gain 
(or magnitude), phase shift, and coherence.
The gain, or transfer magnitude, quantifies the damping effect between the input 
and output of the transfer function. Provided that in Figure 2, waveform 1 is the 
input and waveform 2 is the output of the transfer function, the regulator in this 
system attenuates the amplitude of the input (A), yielding a low value for gain.
In the transfer function between BP and CBFV, the gain represents the damping 
effect of CA on the magnitude of the BP oscillations. The gain of this transfer 
function marks the efficiency of the regulator, which is the response of CA. A low 
gain indicates an efficient autoregulation, whereas an increase in gain represents 
a diminished efficiency of the dynamic process of CA. According to the high-pass 
filter model of CA, the gain rises with increasing frequencies of BP oscillations.54
A specific problem in the interpretation of gain is that absolute measures of gain 
(estimated from transfer function analysis of absolute changes in CBFV and BP) 
are influenced by baseline values of CBFV and BP. Especially for CBFV, 
interindividual differences can be substantial and reflect the differences in MCA 
diameter rather than baseline differences in flow. Therefore, normalization of gain 
has been proposed. This can be achieved by substituting gain by the product of 
gain and CVR, named normalized gain. If the CVRi is determined from averaged 
baseline values for BP and CBFV, normalized gain is mathematically similar to 
gain calculated from relative changes in BP and CBFV.73,74
The second parameter of the transfer function we will discuss is the phase shift. 
Synchronous waveforms are ‘in phase.’ The phase shift of a waveform therefore 
represents the displacement of this waveform relative to another waveform with 
the same period (Figure 2). The phase shift can be expressed in degrees from 01 
to 3601, or in radians from 0 to 2 p, thus ranging from no phase shift to a phase 
shift of one full period. The phase shift can be recalculated to a time difference 
between two signals: a 901 phase shift between two signals with 10-sec periods 
equals a time delay of 2.5 secs between these signals.
The oscillations of CBFV do not occur simultaneous to those of BP. Changes in 
CBFV recover faster than the changes in BP, which causes a displacement of 
CBFV relative to BP in such a manner that CBFV oscillations appear to lead BP
oscillations. This is interpreted as intact dCA.75 In relation to BP, this leftward shift 
is mathematically negative. However, in literature, the phase shift between BP and 
CBFV is often given as a positive number and is defined as a ‘phase lead’. A 
positive phase indicates an intact CA, whereas in patients with a complete loss of 
CA, the phase shift between CBFV and BP is expected to be close to 01. In a 
clinical population of patients with carotid stenosis or occlusion, phase shifts were 
significantly lower than in normal subjects and could sometimes approach 01.56,76
Phase shifts can be considered surrogate measures for the time delay of the 
autoregulatory response. When we translate the phase shift to the time domain, a 
phase shift of 0 means no time delay between oscillations of BP and CBFV.
The measurement of phase shifts and gain is applicable to all stationary models 
that induce oscillatory BP and CBFV changes, and these parameters have an 
apparent relationship to the rate of autoregulation. During induced oscillations in 
the three frequencies regions (the high, > 0.2 Hz; low, 0.07 to 0.20 Hz; and very 
low frequencies, < 0.07 Hz), the gain values increased and the phase shifts 
decreased with increasing frequency.54 Analysis of spontaneous oscillations 
yielded the same results.71,72 These results all confirm the high-pass filter model of 
dynamic CA. In assessing dCA, gain should be calculated in combination with 
phase shifts. For the calculation of phase shifts during an short, nonstationary 
BP/CBFV response, multimodal pressure-flow analysis has been introduced as a 
mathematical tool.77
The third parameter of the transfer function the coherence function tests the 
linearity of the relation between input and output. Coherence approaching unity in 
a specific frequency range suggests a linear relationship in this domain, whereas 
coherence approximating zero may indicate no relationship between the signals. 
However, a low coherence could also indicate severe extraneous noise in the 
signals.70,78 Therefore, for the calculation of phase shifts and gain values, 
thresholds of coherence of >0.4 or >0.5 have been used by most researchers.71,72 
Conversely, low coherence can also be an expression of the nonlinear qualities of 
dCA, and the validity of using these cutoff and maximum points is debatable.79 A 
solution to this limitation is to induce oscillatory changes in BP and CBFV. Several 
maneuvers (as described above) induce oscillations. These enlarge the power of 
the oscillations and thereby the coherence of the transfer function.54 These 
maneuvers can be performed in the different frequency regions. Another possible 
solution is nonlinear analysis and the use of more complex mathematical models.
In accordance with the high-pass filter model of dCA, in healthy older people, 
values of coherence and gain are the highest in the high-frequency region of BP 
oscillations and the lowest in the very low frequency region, whereas phase shifts
are the highest in the very low frequency region and the lowest in the high- 
frequency region.14,71,80
Dynamic Cerebral Autoregulation in Elderly Subjects 
Healthy Elderly
To include all the literature regarding the dynamic process of CA in healthy elderly 
subjects, we performed a literature search with the following search terms: 
cerebrovascular circulation, cerebrovascular disorders, and aged. Furthermore, we 
used free text words, aging, ageing, elderly and the found eight studies that have 
investigated dCA in healthy elderly subjects.81-83 These studies compared the 
autoregulatory capacity of healthy young subjects with healthy aged people. An 
overview of these studies is presented In Table 2. The age range was 50 to 75 
years. All studies measured BP and assessed CBFV in the MCA, using TCD; one 
study also measured CBFV in the posterior cerebral artery (PCA).84 Unfortunately, 
important methodological differences exist among these studies in the 
measurements and assessments of dCA.
Table 2: dynamic cerebral autoregulation in healthy, elderly people
Authors Study sample Measurement Assessment dynamic CA Conclusion
Lipsitz et a l.14 N=10, age 24 
+/- 1 years 
N=10, age 72 
+/- 3 years 
N=10, age 72 
+/- 2 years
Continuous cerebral blood Transfer function analysis
flow velocity (CBFV) and
blood pressure (BP)
measurements during
standing and steady-state
sitting and standing
Elderly
normotensive and 
previously treated 
hypertensive elderly 
subjects retain 
dynamic cerebral 
autoregulation (CA)
Carey et al. 81 N=27, 29 +/- 5 
years
N=27, 68 +/- 5 
years
Changes CBFV and BP Autoregulatory index 
were measured during: values of each subject for 
lower body negative each dynamic (de)pressor 
pressure release, valsalva stimulus; step response 
maneuvre, spontaneous analysis 
rises, thigh cuff test, 
spontaneous falls
Dynamic CA is 
unaffected by aging
Narayanan80 N=10, age 24 
+/- 1 years 
N=10, age 72 
+/- 3 years
CBFV and BP recordings 
of oscillations during 
sitting and standing
Transfer function analysis Dynamic CA in 
healthy elderly 
subjects is intact in 
the low frequency 
range
Carey et al.82 N= 25, 28 +/- 8 
years
N=25, 69 +/-10 
years (five very 
elderly, >75 
years)
Changes in CBFV and BP Autoregulatory index 
were measured during 
head-up tilt
Dynamic CA during 
orthostatic stress is 
unaffected by aging
Heckmann et 
al.85
N=18, 29,4 +/- 
4,7 years 
N=18, 66,5 +/-
Continuous monitoring of 
CBFV and BP during 
ergomotor exercise
Pulsatility index Cerebral 
autoregulatory 
capacity is retained
Authors Study sample Measurement Assessment dynamic CA Conclusion
5.8 years but delayed in 
elderly subjects
Sorond et 
al.84
N=13, 30 (7) 
years
N=13, 74 (4) 
years
Continuous CBFV and BP Rate of recovery 
measurements in 
response to standing from 
a sitting position
Older participants 
have a similar 
decline in CBFV in 
both territories and 
a significantly larger 
CBFV decline in the 
posterior cerebral 
artery compared to 
the middle cerebral 
artery.
Yam et al. 69 N=16, age 28 
+/- 5 years 
N=16, age 54 
+/- 8 years
CBFV and BP recordings 
of spontaneous 
oscillations
Correlation index No correlation 
between age and 
correlation index
Franke et N=10, 72 +/- 1 CBFV continuous Cerebrovascular Older subjects
al.83 years
N=10, 73 +/- 2 
years
N=10, 23 +/-1 
years
N=10, 23 +/-1 
years
measurements; BP 
assessment every minute
resistance, pulsatility index autoregulate CBFV
as well as younger 
subjects regardless 
of fitness
Different investigators measured spontaneous oscillations of BP and CBFV during 
sitting and standing, and calculated transfer functions (resulting in values of gain, 
phase shifts, and coherence) in elderly people.14,80 Yam et al.69 also made use of 
spontaneous BP and CBFV recordings in moderately aged people, but these 
investigators calculated the correlation index between BP and CBFV. Sorond et 
al.84 measured BP and CBFV in elderly subjects during a sit-to-stand procedure 
and evaluated the rate of recovery of CBFV. Carey et al.81,82 used lower body 
negative pressure, the Valsalva maneuver, spontaneous oscillations, the thigh cuff 
test and head-up tilt to induce BP changes, and for each test they assessed the 
autoregulatory index. These investigators measured dCA in 25 aged subjects, 
including five subjects > 75 years. Heckmann et al.85 determined dCA during
83ergomotor exercise in older subjects and calculated the PI. Franke et al.83 
assessed the PI in two different groups of elderly people; one group of fit elderly 
subjects and another group of frail elderly subjects. They measured CBFV 
continuously, but assessed BP only once every minute. To determine dCA, BP 
should ideally be measured continuously.
Regardless of the method by which it was assessed, all studies concluded that 
in healthy aged subjects, dCA is preserved during induced decreases in BP and 
during spontaneous oscillations in BP in the low-frequency range (0.07 to 0.20 
Hz). In the high-frequency range (> 0.15 Hz), dCA is less efficient in both young
and older people.14 This is in agreement with the concept that the relationship 
between CBFV and BP can be expressed by transfer function analysis using a 
high-pass filter model (see above). The studies that calculated changes in the 
CVRi and the PI also concluded that cerebral autoregulatory capacity is retained, 
regardless of physical fitness.83,85 However, these investigators noted that the 
change of the PI in healthy elderly is delayed during ergomotor exercise compared 
with young subjects.85 The CVRi and the PI only have a quantitative relationship 
under stable conditions, and therefore these parameters are difficult to interpret 
during exercise.
Most investigators studied dCA in the MCA, but the PCA can also be insonated 
with the TCD19, and dCA can be investigated in the posterior circulation. Sorond et 
al.84 observed that CBFV in the PCA declined to a greater extent than in the MCA. 
In both young and aged humans, the characteristics of dCA in the PCA differ from 
that in the MCA. The regulation of CBFV in the PCA to spontaneous BP 
oscillations acts as a high-pass filter similar to the MCA.86 The phase shifts in the 
PCA suggest that the latency of CA is sufficient, as it is in the MCA territory, but in 
all frequency ranges, the gain values in the PCA were significantly higher 
compared with the values in the MCA. These higher magnitudes do not 
necessarily indicate an inefficient autoregulation in the PCA, considering the 
similar phase shifts. This dissimilarity in gain more likely is reflective of the different 
resonance properties of the two vascular beds and of the combination of different 
flow and different vessel diameters; flowvelocity in the MCA is approximately 1.5 
times higher than in the PCA.84,86 In summary, no evidence was found for an effect 
of aging on dCA in the age ranges studied (50 to 75 years). Whether dCA is 
preserved at more advanced age (> 75 years) is at present unknown
CA in Aging and Comorbidity
With TCD, CBFV can be measured during gradual and prolonged changes in BP, 
cf. the classic method to determine CA.87 Under normal conditions, the upper and 
lower limits of CA are found at 60 and 150mm Hg mean arterial pressure, 
respectively. The important difference between the measurement of classic and 
dynamic CA is that the classic measurements are performed in the semisteady 
state and that the use of vasoactive medication is necessary to drive these 
prolonged changes in BP. In contrast to this approach, dCA measures flow 
changes in response to BP fluctuations that are mostly within the limits of 
autoregulation.
In one study in normal human subjects, dynamic measurement of CA yielded 
results similar to static testing under conditions of intact autoregulation and
following pharmacologically induced impairment of autoregulation.65 However, very 
few studies have combined estimations of sCA and dCA. Therefore, further 
research should combine sCA and dCA and attempt to describe the behavior of 
dCA around the lower and upper limits of BP as identified by the classic sCA 
curve.
However, for clinical applications, dynamic measurements of CA are probably 
the method of choice. This practice is noninvasive and less prolonged, it could be 
performed at bedside, and pharmacological interventions are not necessary.
Diseases such as acute ischemic stroke may bilaterally impair sCA leaving the 
brain tissue unprotected against the potentially harmful effect of BP changes.1 
Stroke is more common in older subjects, and 72 to 96 h after an acute stroke, 
dCA is bilaterally impaired, rendering CBFV dependent on BP.7,88 Reinhard et 
al.61,76,89 found no major disturbance of dCA after 4 to 48 h after stroke. However, 
after 72 to 171 h, they found a trend toward poorer autoregulatory values. 
Therefore, it could be argued that in poststroke patients, BP should be well 
controlled to stabilize CBF and to prevent cerebral hyperperfusion or ischemia. 
However, which levels of BP are acceptable in the acute stroke phase, and to 
which level BP can or should be lowered, is still uncertain.90
Further research addressing the dynamic pressure-flow relationship in acute 
stroke may help to shed light on this important issue.
For hypertensive patients, estimations of CA offer a simple method to evaluate 
not only the effect of hypertension but also the effect of antihypertensive treatment 
on cerebral perfusion. Because of an upward shift of the lower limit of the sCA 
curve toward higher pressure, and with this, a possible impaired tolerance to a 
decline in BP, a conservative approach in elderly patients with hypertension has 
been suggested.91 However, classic studies of sCA have shown that this rightward 
shift with hypertension undergoes a leftward shift with treatment92 Indeed, with 
dCA, middle-aged and elderly (< 75 years) hypertensive patients were found to 
retain the ability to maintain CBFV in the face of acute BP changes, assessed by 
the autoregulatory index during different maneuvers.93 Using the autoregulatory 
index during the Valsalva maneuver, Novak et al.77 did not find any difference 
between healthy normotensive and hypertensive middle-aged subjects. However, 
when they used the multimodal pressure-flow analysis, they observed a smaller 
phase shift pointing toward less efficient autoregulation in the hypertensive group. 
In patients with controlled hypertension, the cerebral autoregulatory response was 
preserved.94 In newly diagnosed middle-aged patients with untreated mild to 
moderate hypertension, dCA was normal. Shortand long-term reduction of BP did 
not compromise dCA.15 Furthermore, in uncontrolled hypertensive patients with a
mean age of 72 years, 6 months of successful, aggressive treatment with 
antihypertensive therapy increased CBFV significantly compared with controlled 
hypertensive patients and healthy controls.16 This therapy did not impair dCA 
assessed with an active sit-to-stand procedure.
Autoregulation studies can contribute valuable clinical information regarding 
CBF control by identifying or confirming patients at high risk for impaired cerebral 
perfusion. Transient cerebral hypoperfusion can lead to syncope, which is a 
common medical problem in the elderly.95 In addition, many older patients are 
vulnerable to cerebral hypoperfusion after orthostatic BP decreases.10 The 
combined mechanisms of (baroreflex mediated) BP regulation and CA limit the 
reduction of the cerebral perfusion induced by the postural position. However, if, 
despite these protective mechanisms, cerebral perfusion becomes impaired, 
symptoms of orthostatic hypotension such as dizziness and syncope occur.96 For 
recurrent falls among elderly subjects, orthostatic hypotension is an independent 
risk factor, but orthostatic hypotension alone may not be sufficient to produce 
symptoms like falls in most elderly patients.97 In contrast, decreases in standing 
BP that are smaller than the formal definition of orthostatic hypotension (a 
decrease of 20mm Hg or more) may exceed the threshold for CA in some patients 
and therefore be sufficient to cause cerebral hypoperfusion. In many patients with 
orthostatic hypotension, BP remains within the autoregulatory range. Because of 
CA, the effect of a given change in BP on cerebral perfusion cannot be predicted.
Conclusion
Classic studies regarding CA are performed in the semi-steady state, and they 
measure CBF after a persistent change in BP with a gradual onset. In contrast, 
recent studies have investigated the fast modifications of CBF in relation to rapid 
changes in BP. Technological developments, such as TCD and servo-controlled 
finger photoplethysmography, have offered the possibilities to investigate more 
thoroughly the dynamics of the process of CA. This dynamic approach is the most 
promising approach for the clinical evaluation of CA. These measurements are 
less time consuming, entirely noninvasive, and could be performed at bedside. 
However, no uniform method exists to assess the dynamic cerebral autoregulatory 
capacity of the human brain. Researchers have introduced several techniques to 
challenge CA, ranging from a single episode of induced hypotension to induced 
oscillatory changes in BP, and additionally have used spontaneous BP oscillations 
to quantify dCA. The quantifications used vary from calculated indices using 
regression analysis to rate of CVR changes and to transfer function analysis. We
have provided an overview of the various methods applied to study CA 
dynamically.
Subsequently, we have reviewed the literature regarding dCA in healthy elderly 
subjects. Regardless of the assessment used, dCA is preserved in healthy elderly 
subjects < 75 years. Owing to this intact dCA, a lowering of BP should not 
influence CBF. However, in diseases affecting the elderly, symptoms of cerebral 
hypoperfusion are frequent. Testing the dynamic cerebral autoregulatory capacity 
could be a promising tool to determine the risk of hypoperfusion and ischemia of 
the brain. To determine dCA during orthostatic stress, the sit-to-stand procedure is 
a feasible method in elderly patients. Baseline measurements of spontaneous 
fluctuations in BP and CBFV are elegant measurements to assess dCA and ask 
little of the patient. If the magnitude of the spontaneous oscillations in BP is not 
high enough to assess dCA (i.e., coherence is < 0.4), it may be necessary to 
induce oscillations with any of the methods described above. In both situations, 
CBFV in relation to BP can then be expressed by transfer function analysis using a 
high pass-filter model resulting in values of gain, phase, and coherence. More 
clinical studies are necessary to investigate the effect of a truly old age (80 years 
and older) and comorbidity on the dynamic pressure-flow relationship. At present, 
technological developments have given good prospects to study this relationship 
in the elderly population.
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